Patent · US Active

Nanoparticulate meloxicam formulations

US10463673B2 · kind B2 · utility

3Cited by
85References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2018
Grant dateNov 5, 2019
Priority date
Expiry dateApr 11, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.